Quanzhou Banbao Trading Co., Ltd – Trademark Portfolio

Entity Type: 16

Quanzhou Banbao Trading Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include AMINKINA and GLORIXEN. The owner is based in Quanzhou City.

No. 199, Bailian Rd., Chun Village, Baiqi Hui Nationality Township, Quanzhou Taiwan Investment Zone

Quanzhou City 362000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GLORIXEN
GLORIXEN
Registered 2024
AMINKINA
AMINKINA
Registered 2022

Trademark Classifications

Quanzhou Banbao Trading Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (2 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Quanzhou Banbao Trading Co., Ltd have?

Quanzhou Banbao Trading Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Quanzhou Banbao Trading Co., Ltd file in?

Quanzhou Banbao Trading Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 14 (Jewelry). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Quanzhou Banbao Trading Co., Ltd's most well-known trademarks?

Quanzhou Banbao Trading Co., Ltd's registered trademark portfolio includes well-known marks such as AMINKINA and GLORIXEN. These are among 2 currently registered trademarks in the portfolio.

What is Quanzhou Banbao Trading Co., Ltd's trademark registration success rate?

Quanzhou Banbao Trading Co., Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.